Abstract: Disclosed herein are system, method, and computer program product embodiments system of migration and validation. An embodiment operates by receiving an indication of a plurality of documents for migration from a legacy data format to a new data format of a computing system. A first set of data statistics corresponding to a selected one of the subset of documents prior to a performance of the migration, and a second set of data statistics corresponding to the selected document after the performance of the migration are determined. Both the first set of data statistics and the second set of data statistics side-by-side for the selected document are displayed. An indication whether the migration is validated or invalidated is received.

Abstract: Disclosed herein are system, method, and computer program product embodiments system of migration and validation. An embodiment operates by receiving an indication of a plurality of documents for migration from a legacy data format to a new data format of a computing system. A first set of data statistics corresponding to a selected one of the subset of documents prior to a performance of the migration, and a second set of data statistics corresponding to the selected document after the performance of the migration are determined. Both the first set of data statistics and the second set of data statistics side-by-side for the selected document are displayed. An indication whether the migration is validated or invalidated is received.

Abstract: Disclosed herein are system, method, and computer program product embodiments system of migration and validation. An embodiment operates by receiving an indication of a plurality of documents for migration from a legacy data format to a new data format of a computing system. A first set of data statistics corresponding to a selected one of the subset of documents prior to a performance of the migration, and a second set of data statistics corresponding to the selected document after the performance of the migration are determined. Both the first set of data statistics and the second set of data statistics side-by-side for the selected document are displayed. An indication whether the migration is validated or invalidated is received.

Abstract: The present invention describes phenylpiperazinyl alpha adrenergic antagonists that corresponds to the formula (I) which selectively act on the alpha 1A/alpha 1D subtypes, where its selectivity index in comparison to alpha 1B subtype is, at minimum, 1700 for the alpha 1A subtype and 10000 for the alpha 1D subtype, being therefore useful for the treatment of the lower urinary tract symptoms, including the benign prostatic hyperplasia treatment in mammals, preferentially humans. Also described are pharmaceutical compositions containing said compounds and methods for its preparation.